Abstract:The relationship between obstructive sleep apnea (OSA) and endocrine and metabolic disease is unequivocal. OSA, which is characterized by intermittent hypoxia and sleep fragmentation, leads to and exacerbates obesity, metabolic syndrome, and type 2 diabetes (T2D) as well as endocrine disturbances, such as hypothyroidism and Cushing syndrome, among others. However, this relationship is bidirectional with endocrine and metabolic diseases being considered major risk factors for the development of OSA. For example, polycystic ovary syndrome (PCOS), one of the most common endocrine disorders in women of reproductive age, is significantly associated with OSA in adult patients. Several factors have been postulated to contribute to or be critical in the genesis of dysmetabolic states in OSA including the increase in sympathetic activation, the deregulation of the hypothalamus-pituitary axis, the generation of reactive oxygen species (ROS), insulin resistance, alteration in adipokines levels, and inflammation of the adipose tissue. However, probably the alterations in the hypothalamus-pituitary axis and the altered secretion of hormones from the peripheral endocrine glands could play a major role in the gender differences in the link between OSA-dysmetabolism. In fact, normal sleep is also different between men and women due to the physiologic differences between genders, with sex hormones such as progesterone, androgens, and estrogens, being also connected with breathing pathologies. Moreover, it is very well known that OSA is more prevalent among men than women, however the prevalence in women increases after menopause. At the same time, the step-rise in obesity and its comorbidities goes along with mounting evidence of clinically important sex and gender differences. Metabolic and cardiovascular diseases, seen as a men's illness for decades, presently are more common in women than in men and obesity has a higher association with insulin-resistance-related risk factors in women than in men. In this way, in the present manuscript, we will review the major findings on the overall mechanisms that connect OSA and dysmetabolism giving special attention to the specific regulation of this relationship in each gender. We will also detail the gender-specific effects of hormone replacement therapies on metabolic control and sleep apnea.

Gender differences in obstructive sleep apnea syndrome: a pilot study

Gender differences of clinical and polysomnographic findings with obstructive sleep apnea syndrome

Gender Differences in the Polysomnographic Features of Obstructive Sleep Apnea

Analysis of gender differences in clinical features of obstructive sleep apnea

0481 Sex Differences in Moderate-Severe Obstructive Sleep Apnea Diagnosis using Different Sleep Study Modalities

Characterization of obstructive sleep apnea in patients with insomnia across gender and age

Sex-specific differences in presenting symptoms of obstructive sleep apnea

Clinical characteristics and polysomnography in female patients with obstructive sleep apnea hypopnea syndrome

Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome

Differences in Biological Features Between Male and Female Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Is the clinical presentation different between men and women admitting to the sleep laboratory?

Gender differences in obesity hypoventilation syndrome

Gender Differences in the Context of Obstructive Sleep Apnea and Metabolic Diseases

Sex Differences in Obstructive Sleep Apnea Including Pregnancy and Response to Treatment

Gender differences in oral appliance treatment of obstructive sleep apnea

Gender characteristics of obstructive sleep apnea syndrome clinical manifestations and patients' quality of life

Sex differences in sleep and sleep-disordered breathing

Sex Differences in Obstructive Patterns on Drug-Induced Sleep Endoscopy

Age and Severity Matched Comparison of Gender Differences in the Prevalence of Periodic Limb Movements During Sleep in Patients with Obstructive Sleep Apnea

Inflammation markers in moderate and severe obstructive sleep apnea: the influence of sex

Sex Differences in the Expression of Cardiac Remodeling and Inflammatory Cytokines in Patients with Obstructive Sleep Apnea and Atrial Fibrillation